Watching a single enzyme switch from a standstill to full sprint while decoding DNA inside a mammalian cell would have sounded like science fiction not long ago, yet that leap just became a measurable reality thanks to a single-molecule transcription platform that links factor binding to RNA
Rising demand, tighter budgets, and complex patients have pushed cardiovascular imaging from supporting act to central protagonist, and that shift is on full display in Vienna as echo, CMR, CT, and nuclear cardiology share one stage from December 11–13. Congress organizers set a clear purpose:
Ivan Kairatov has spent years at the intersection of structural biology and biopharma, translating difficult, dynamic molecules into practical insights that can power new therapeutics. In this conversation, he unpacks a “molecular film” of a self-splicing ribozyme—captured almost frame by frame—and
In operating rooms where silence often amplifies stress, a small change—a pair of headphones and a vigilant recovery plan—can shift the arc of the first hours after colorectal cancer surgery, easing the path from anesthesia to wakefulness while trimming complications that make families and
Chronic HIV infection, even under suppressive antiretroviral therapy, can trap the immune system in a state of simmering alarm that never fully resolves and quietly erodes the fitness of the very T cells needed for durable control of the virus. That conundrum has intensified attention on the small
In emergency rooms, prenatal clinics, and primary care offices alike, clinicians reach for ultrasound because it delivers immediate answers without exposing patients to ionizing radiation, yet it still runs through the same radiology workflows that govern X-rays and CT. That dual identity raises a
In an era where supply chain resilience and access to life-saving therapies dominate healthcare discussions, AstraZeneca's announcement of a $2 billion investment in Maryland facilities has captured significant attention, raising critical questions about domestic production. This ambitious
In a world where a stroke strikes someone every 40 seconds, the fear of a second, potentially fatal event looms large for millions of survivors, creating an urgent need for better solutions. Picture a patient, just recovered from an initial stroke, grappling with the uncertainty of whether their
In the rapidly evolving landscape of biotechnology, few companies have captured the imagination of investors and industry watchers quite like Recursion Pharmaceuticals (NASDARXRX). Headquartered in Salt Lake City, Utah, this clinical-stage “TechBio” firm is at the forefront of a paradigm shift,
In a remarkable advancement that could alter the landscape of cancer care, researchers from University College London (UCL) and the University of Oxford have developed LungVax, the world’s first experimental vaccine aimed at preventing lung cancer. This pioneering initiative, now entering clinical
